Skip to content

Shi's Yi-Qi Bu-Shen Tong-Luo decoction combined with manipulation in the management of wrist stiffness after distal radius fracture: a single-center, double-blinded randomized controlled trial

Shi's Yi-Qi Bu-Shen Tong-Luo decoction combined with manipulation in the management of wrist stiffness after distal radius fracture: a single-center, double-blinded randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000002931
Enrollment
Unknown
Registered
2020-01-19
Start date
2020-03-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Radius Fracture

Interventions

Sponsors

Huangpu Branch, Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
48 Years to 78 Years

Inclusion criteria

Inclusion criteria: (1) patients with clear diagnosis of unilateral distal radius fracture and receiving conservative treatment such as plaster external fixation, small splint fixation and external fixation stent; (2) patients aged 48 to 78 years old; (3) clinical healing of the fracture, that is, X-ray 6 weeks after the fracture showed blurred fracture line and good callus growth, and external fixation such as plaster and support was removed; (4) after 6 weeks of fracture, wrist dysfunction, stiffness, local swelling and pain were observed, and the range of motion of the joint was significantly lower than that of the healthy side; (5) oral Chinese medicine and manipulation therapy are acceptable; (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with allergic constitution or allergic to the test drugs or patients with serious adverse reactions to the test drugs; (2) the fracture site has poor stability and is prone to redisplacement during rehabilitation; (3) nerve injury in the affected limb or severe osteoporosis; (4) cancer patients; (5) mental disorders such as mania and depression; (6) those with a history of infectious diseases, such as tuberculosis, hepatitis b, HIV and other infectious diseases; (7) medical diseases with poor control, such as diabetes, hyperlipidemia, respiratory tract infection, etc.; (8) having a history of abuse of opioid analgesics, sedatives and hypnotics and alcohol; (9) severe liver or kidney disease or severe damage to liver and kidney function (ALT or AST is more than 1.5 times higher than the normal upper limit, and blood creatinine is more than 1.5 times higher than the normal upper limit); (10) poor compliance, inability to cooperate with techniques and to meet the requirements of follow-up; (11) patients who participated in clinical trials of other drugs within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Cooney Wrist Score;

Secondary

MeasureTime frame
the MOS item short from health survey, SF-36;Numerical rating scale;adverse events;Patient-Rated Wrist Evaluation Score;

Countries

China

Contacts

Public ContactHaiyang Wu
286948197@qq.com+86 17601284900

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026